SCHEMBL8068087

SCHEMBL8068087

Nc1nc(OC2O[C@H](CO)[C@@H](O)[C@H]2O)c2[nH]cnc2n1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CDK1 P06493 18/20 0.47
▸ CCNB1 P14635 18/20 0.47
▸ CCNA2 P20248 17/20 0.47
▸ CDK2 P24941 17/20 0.47
▸ CCNA1 P78396 17/20 0.47
▸ MGMT P16455 7/20 0.47
▸ PIN1 Q13526 3/20 0.46
▸ CCNB2 O95067 1/20 0.46
▸ MAPK3 P27361 1/20 0.46
▸ CLK1 P49759 1/20 0.46
▸ CDK5 Q00535 1/20 0.46
▸ CCNB3 Q8WWL7 1/20 0.46
▸ MAP3K5 Q99683 1/20 0.46
▸ LMNA P02545 1/20 0.44
▸ CYP1A2 P05177 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ CYP2D6 P10635 1/20 0.44
▸ CYP2C9 P11712 1/20 0.44
▸ TSHR P16473 1/20 0.44
▸ NFKB1 P19838 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8059232 0.99 CDK1 (0.46) CDK1CCNB1CCNA2CDK2CCNA1
SCHEMBL11130951 0.86 SLC5A2 (0.43) —
SCHEMBL2941560 0.86 ALDH1A1 (0.41) —
SCHEMBL11133877 0.84 SLC5A2 (0.44) —
SCHEMBL97672 0.83 PDPK1 (0.46) CDK1CDK2
SCHEMBL568026 0.83 PDPK1 (0.46) CDK1CDK2
Methylguanine SCHEMBL34851 0.83 CDK1 (0.51) CDK1CCNB1CCNA2CDK2CCNA1
2,6-Diaminopurine SCHEMBL6241914 0.78 PDPK1 (0.59) CDK1CCNB1CCNA2CDK2CCNA1
2,6-Diaminopurine SCHEMBL10774603 0.78 PDPK1 (0.59) CDK1CCNB1CCNA2CDK2CCNA1
2,6-Diaminopurine SCHEMBL2934952 0.78 PDPK1 (0.59) CDK1CCNB1CCNA2CDK2CCNA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1017394-A1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-07-12 — — EP claimed
WO-1999002162-A9 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RES CAMPAIGN TECH (GB) 1999-07-29 — — WO claimed
WO-1999002162-A1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1999-01-21 — — WO claimed
EP-1017394-A1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 2000-07-12 — — EP disclosed
WO-1999002162-A9 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RES CAMPAIGN TECH (GB) 1999-07-29 — — WO disclosed
WO-1999002162-A1 CYCLIN DEPENDENT KINASE INHIBITING PURINE DERIVATIVES CANCER RESEARCH CAMPAIGN TECHNOLOGY LIMITED (GB) 1999-01-21 — — WO disclosed
Send feedback